Evaluation and Management of the Patient with Severe Tricuspid Regurgitation from the Surgical Perspective
Rick Nishimura and Michael Mack outline the evolving role of surgery in the treatment of severe tricuspid regurgitation patients.
Tricuspid Valve Academic Research Consortium-2 (TVARC-2): Trial Design and Endpoints
In this preplanned Tricuspid Valve Academic Research Consortium-2 (TVARC-2) consensus document, we seek to utilize the definitions and principles described in TVARC-1 to create Chapter 2. Specifically, TVARC-2 proposes trial designs and endpoints to inform future transcatheter tricuspid valve intervention investigation.
Echocardiographic Evaluation of the Patient with Tricuspid Regurgitation with Rick Nishimura and Paul Grayburn
Rick Nishimura and Paul Grayburn discuss the role of echocardiography in properly evaluating and managing TR patients.
Transcatheter Tricuspid Valve Interventions
Rick Nishimura and Paul Sorajja discuss how catheter-based approaches can help patients with severe symptomatic tricuspid regurgitation.
An Overview of Surgery in TR
Michael Mack speaks with Francesco Maisano about the surgical management of tricuspid regurgitation.
Heart Failure Management
Patrick O’Gara speaks with Sean Pinney about the evaluation and treatment of patients with severe tricuspid regurgitation.
EP Considerations
Pat O’Gara and Laurence Epstein discuss rhythm and device considerations in patients with tricuspid regurgitation.
Managing Implanted Cardiac Electronic Devices in Patients with Severe Tricuspid Regurgitation: JACC State-of-the-Art Review
This state-of-the-art review attempts to define the patient population with cardiac implantable electronic device (CIED) lead-associated or lead-induced tricuspid regurgitation, delineate the risks and benefits of transvenous lead extraction in this setting, and develop a management algorithm for patients considered for valve replacement.
Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
This Academic Research Consortium (ARC) document standardizes definitions of disease etiology and severity, as well as endpoints for trials that aim to address the gaps in knowledge related to identification and management of patients with tricuspid regurgitation.